| Heading: |
NHS: Drugs |
| Question ID: |
1752183 |
| UIN: |
21744 |
| House: |
Commons |
| Date tabled: |
2025-01-03 |
| Asking Member ID: |
5101 |
| Asking Member display name: |
Sir Ashley Fox
|
| Asking Member handle: |
Ashley7Fox
|
| Asking Member Twitter reference: |
@Ashley7Fox
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, whether his Department is taking steps to decrease the amount of time it takes for a repurposed medicine to be granted an MHRA licence. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-01-09 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The Medicines and products Regulatory Agency (MHRA) reviews the efficacy, safety and quality of a repurposed medicine in a similar way to other medicinal applications. This review is part of the activities which MHRA contributes to under the Medicines Rep... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |